Robert Walpole is a seasoned executive with extensive experience in leading global teams within the oncology diagnostics sector. They have a proven track record in commercialization, corporate strategy, and product marketing, with leadership roles at Roche Diagnostics and Illumina. Currently, Robert serves as the Director of Oncology Marketing at Natera, focusing on the commercialization of therapy selection solutions. They hold an MBA from MIT Sloan School of Management and have previously worked in finance and product management at companies like Qualcomm and Hewlett-Packard.